Ipsen Biopharmaceuticals Inc - Strategic SWOT Analysis Review

September 2021 | 22 pages | ID: I27A3B250FFEN
GlobalData

Abstracts

Ipsen Biopharmaceuticals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – GlobalData’s summarization of the company’s business strategy.
• SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Ipsen Biopharmaceuticals Inc (Ipsen), a subsidiary of Ipsen SA, is a biotechnology company that develops and commercializes pharmaceuticals in the areas of neurology and endocrinology. The company's product portfolio encompasses Increlex (mecasermin) injection indicated for the treatment of children suffering from short stature due to severe primary IGFD; Onivyde injection indicated for the treatment of patients with metastatic adenocarcinoma of the pancreas; Somatuline Depot (lanreotide) injection used to treat acromegaly and neuroendocrine tumors; and Dysport (abobotulinumtoxinA) injection indicated for the treatment of adults with cervical dystonia, upper limb spasticity, and pediatric patients with lower limb spasticity. The company has partnership with biopharmaceutical companies, scientific and clinical communities to develop new therapies against endocrine and metabolic diseases. Ipsen is headquartered in Basking Ridge, New Jersey, the US.

Ipsen Biopharmaceuticals Inc Key Recent Developments

Jul 16,2021: Ipsen and IRLAB sign $363m deal for Parkinson’s disease therapy

Reasons to Buy

• Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
• Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
• Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
• Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Contents

SECTION 1 - ABOUT THE COMPANY

Ipsen Biopharmaceuticals Inc - Key Facts
Ipsen Biopharmaceuticals Inc - Key Employees
Ipsen Biopharmaceuticals Inc - Key Employee Biographies
Ipsen Biopharmaceuticals Inc - Major Products and Services
Ipsen Biopharmaceuticals Inc - History
Ipsen Biopharmaceuticals Inc - Company Statement
Ipsen Biopharmaceuticals Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Ipsen Biopharmaceuticals Inc - Business Description
Ipsen Biopharmaceuticals Inc - Corporate Strategy
Ipsen Biopharmaceuticals Inc - SWOT Analysis
SWOT Analysis - Overview
Ipsen Biopharmaceuticals Inc - Strengths
Ipsen Biopharmaceuticals Inc - Weaknesses
Ipsen Biopharmaceuticals Inc - Opportunities
Ipsen Biopharmaceuticals Inc - Threats
Ipsen Biopharmaceuticals Inc - Key Competitors

SECTION 3 – COMPANY’S RECENT DEVELOPMENTS

Jul 16, 2021: Ipsen and IRLAB sign $363m deal for Parkinson’s disease therapy

SECTION 4 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Ipsen Biopharmaceuticals Inc, Key Facts
Ipsen Biopharmaceuticals Inc, Key Employees
Ipsen Biopharmaceuticals Inc, Key Employee Biographies
Ipsen Biopharmaceuticals Inc, Major Products and Services
Ipsen Biopharmaceuticals Inc, History
Ipsen Biopharmaceuticals Inc, Subsidiaries
Ipsen Biopharmaceuticals Inc, Key Competitors